S. Zaentz

Stroke intensive care--an appraisal.

F. Kennedy, T. J. Pozen, E. Gabelman, 1970, American heart journal.

V. PRESENCE OF ERYTHROBLAST CYTOTOXICITY IN yG-GLOBULIN FRACTION OF PLASMA

S. Zaentz, Sanford B. KRANrZ, W. H. Moore, 1973 .

Detection of cytotoxic antibody to erythroblasts.

A. Baker, S. Krantz, S. Zaentz, 1977, The Journal of laboratory and clinical medicine.

Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma.

S. Krantz, S. Zaentz, W. H. Moore, 1973, The Journal of clinical investigation.

Studies on pure red cell aplasia. VI. Development of two-stage erythroblast cytotoxicity method and role of complement.

S. Krantz, S. Zaentz, 1973, The Journal of laboratory and clinical medicine.

Studies on Pure Red Cell Aplasia

S. Krantz, D. Sears, S. Zaentz, 2005 .

Studies on Pure Red Cell Aplasia: VIII. MAINTENANCE THERAPY WITH IMMUNOSUPPRESSIVE DRUGS

S. Zaentz, S. Krantz, E. B. Brown, 1976, British journal of haematology.

Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.

G. Rosner, M. Ratain, E. Small, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer.

D. Haller, A. Cnaan, J. Harris, 1994, American journal of clinical oncology.

Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.

E. Eisenhauer, J. Johnston, W. Corbett, 1988, Journal of the National Cancer Institute.

Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.

E. Eisenhauer, J. Johnston, P. Daeninck, 2000, Seminars in oncology.